Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Engineered tissue: ATIS will begin this summer a pivotal trial of its engineered human dermis with synthetic epidermis as a substitute for soft tissue grafts du

Advanced Tissue Sciences Inc. (ATIS), La Jolla, Calif.
Product: Engineered tissue

Read the full 111 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE